Skip to main content
. 2019 Jan 22;3(2):187–197. doi: 10.1182/bloodadvances.2018024075

Figure 4.

Figure 4.

Combining interim PET with clinical risk factors. OS (A) and EFS (B) curves by interim 5PS alone. OS (C) and EFS (D) curves of combined 5PS with PIT. OS (E) and EFS (F) curves of combined 5PS with metabolic tumor volume (TMTV).